Wang B, Chen Y, Ye Z, Yu H, Chan KF, Xu T, Guo Z, Liu W, Zhang L
doi: 10.1111/j.1365-2672.2012.05344.x 93 DhakalRBajpaiVKBaekKH
However, federal law gives states the option whether to cover drugs used for weight loss
GLP-1 Receptor Agonists: Drug Litigation Overview and Trends The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S
If youve never experienced it, its hard to describe it and explain the full scope of it
However, current guidelines do not recommend L-carnitine for cancer-related fatigue (Bower 2024, S3-Leitlinie) and advise against its use for preventing chemotherapy-induced peripheral neuropathy (Loprinzi 2020, Lyman 2018)